Cubosomal based oral tablet for controlled drug delivery of telmisartan: formulation, in-vitro evaluation and in-vivo comparative pharmacokinetic study in rabbits

References

• Šentjurc M, Vrhovnik K, Kristl J. Liposomes as a topical delivery system: the role of size on transport studied by the EPR imaging method. J Control Release. 1999;59:87–97.
   PubMed Web of Science ®Google Scholar
• Gaur PK, Mishra S, Kumar A, et al. Development and optimization of gastroretentive mucoadhesive microspheres of gabapentin by Box–Behnken design. Artif Cells Nanomed Biotechnol. 2014;42:167–177.
   PubMed Web of Science ®Google Scholar
• Drummond CJ, Fong C. Surfactant self-assembly objects as novel drug delivery vehicles. Curr Opin Colloid Interface Sci. 1999;4:449–456.
   Web of Science ®Google Scholar
• Chung H, Kim J, Um YJ, et al. Self-assembled “nanocubicle” as a carrier for peroral insulin delivery. Diabetologia. 2002;45:448–451.
   PubMed Web of Science ®Google Scholar
• Chang C-M, Bodmeier R. Monoglyceride based liquid crystalline topical drug delivery systems. Pharm Res. 1994;11:S185.
   PubMedGoogle Scholar
• Lopes LB, Lopes JL, Oliveira DC, et al. Liquid crystalline phases of monoolein and water for topical delivery of cyclosporin A: characterization and study of in vitro and in vivo delivery. Eur J Pharm Biopharm. 2006;63:146–155.
   PubMed Web of Science ®Google Scholar
• Engstrom S, Ericsson B, Landh T. A cubosome formulation for intravenous administration of somatostatin. Proc Int Symp Control Rel Bioact Mat. 1996;23:89–90.
   Google Scholar
• Chang C-M, Bodmeier R. Low viscosity monoglyceride-based drug delivery systems transforming into a highly viscous cubic phase. Int J Pharm. 1998;173:51–60.
   Web of Science ®Google Scholar
• Boyd BJ, Whittaker DV, Khoo S-M, et al. Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. Int J Pharm. 2006;309:218–226.
   PubMed Web of Science ®Google Scholar
• Norling T, Lading P, Engstrom S, et al. Formulation of a drug delivery system based on a mixture of monoglycerides and triglycerides for use in the treatment of periodontal disease. J Clin Periodontol. 1992;19:687–692.
   PubMed Web of Science ®Google Scholar
• Nielsen LS, Schubert L, Hansen J. Bioadhesive drug delivery systems. I. Characterisation of mucoadhesive properties of systems based on glyceryl monooleate and glyceryl monolinoleate. Eur J Pharm Sci. 1998;6:231–239.
   PubMed Web of Science ®Google Scholar
• Jones DS, Woolfson AD, Brown AF, O’Neill MJ. Mucoadhesive, syringeable drug delivery systems for controlled application of metronidazole to the periodontal pocket: in vitro release kinetics, syringeability, mechanical and mucoadhesive properties. J Control Release. 1997;49:71–79.
   Web of Science ®Google Scholar
• Yaghmur A, Glatter O. Characterization and potential applications of nanostructured aqueous dispersions. Adv Colloid Interface Sci. 2009;147–148:333–342.
   PubMed Web of Science ®Google Scholar
• Almgren M. Vesicle transformations resulting from curvature tuning in systems with micellar, lamellar, and bicontinuous cubic phases. J Dispers Sci Technol. 2007;28:43–54.
   Web of Science ®Google Scholar
• Contescu CI, Putyera K. Dekker Encyclopedia of Nanoscience and Nanotechnology. 2nd ed. Boca Raton: Taylor & Francis; 2009.
   Google Scholar
• Guo C, Wang J, Cao F, et al. Lyotropic liquid crystal systems in drug delivery. Drug Discov Today. 2010;15:1032–1040.
   PubMed Web of Science ®Google Scholar
• Clogston J, Caffrey M. Controlling release from the lipidic cubic phase. Amino acids, peptides, proteins and nucleic acids. J Control Release. 2005;107:97–111.
   PubMed Web of Science ®Google Scholar
• Mohammady SZ, Pouzot M, Mezzenga R. Oleoylethanolamide-based lyotropic liquid crystals as vehicles for delivery of amino acids in aqueous environment. Biophys J. 2009;96:1537–1546.
   PubMed Web of Science ®Google Scholar
• Lipowsky R, Sackmann E. Structure and Dynamics of Membranes. Amsterdam, New York: Elsevier Science; 1995.
   Google Scholar
• Shah JC, Sadhale Y, Chilukuri DM. Cubic phase gels as drug delivery systems. Adv Drug Deliv Rev. 2001;47:229–250.
   PubMed Web of Science ®Google Scholar
• Chung H, Caffrey M. The curvature elastic-energy function of the lipid-water cubic mesophase. Nature. 1994;368:224–226.
   PubMed Web of Science ®Google Scholar
• Fraser S, Separovic F, Polyzos A. Cubic phases of ternary amphiphile-water systems. Eur Biophys J. 2009;39:83–90.
   PubMed Web of Science ®Google Scholar
• Neha S, Sadhna K, Sandeep A. Enhancement of dissolution of telmisartan by surface solid dispersion technique. J Pharm Res. 2012;11:142–149.
   Google Scholar
• Marasini N, Tran TH, Poudel BK, et al. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique. Int J Pharm. 2013;441:424–432.
   PubMed Web of Science ®Google Scholar
• Sangwai M, Vavia P. Amorphous ternary cyclodextrin nanocomposites of telmisartan for oral drug delivery: improved solubility and reduced pharmacokinetic variability. Int J Pharm. 2013;453:423–432.
   PubMed Web of Science ®Google Scholar
• Gaja J, Sayyad F. Enhancement of solubility and dissolution rate of telmisartan by spray drying technique. Indo Am J Pharm Res. 2013;3:1732–1745.
   Google Scholar
• Kundu S, Kumari N, Soni SR, et al. Enhanced solubility of telmisartan phthalic acid cocrystals within the pH range of a systemic absorption site. ACS Omega. 2018;3:15380–15388.
   Web of Science ®Google Scholar
• Morsi NM, Abdelbary GA, Ahmed MA. Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro/in vivo characterization. Eur J Pharm Biopharm. 2014;86:178–189.
   PubMed Web of Science ®Google Scholar
• Esposito E, Eblovi N, Rasi S, et al. Lipid-based supramolecular systems for topical application: a preformulatory study. AAPS PharmSci. 2003;5:62.
   Google Scholar
• Elnaggar YS, Etman SM, Abdelmonsif DA, et al. Novel piperine-loaded Tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer’s disease: pharmaceutical, biological, and toxicological studies. Int J Nanomed. 2015;10:5459.
   PubMed Web of Science ®Google Scholar
• Madheswaran T, Baskaran R, Yong CS, et al. Enhanced topical delivery of finasteride using glyceryl monooleate-based liquid crystalline nanoparticles stabilized by cremophor surfactants. AAPS PharmSciTech. 2014;15:44–51.
   PubMed Web of Science ®Google Scholar
• Lai J, Lu Y, Yin Z, et al. Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles. Int J Nanomed. 2010;5:13.
   PubMed Web of Science ®Google Scholar
• Baskaran R, Madheswaran T, Sundaramoorthy P, et al. Entrapment of curcumin into monoolein-based liquid crystalline nanoparticle dispersion for enhancement of stability and anticancer activity. Int J Nanomed. 2014;9:3119.
   PubMed Web of Science ®Google Scholar
• Sahoo RK, Biswas N, Guha A, et al. Development and in vitro/in vivo evaluation of controlled release provesicles of a nateglinide-maltodextrin complex. Acta Pharm Sin B. 2014;4:408–416.
   PubMed Web of Science ®Google Scholar
• Abdelbary GA, Amin MM, Zakaria MY. Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies. Drug Deliv. 2017;24:309–319.
   PubMed Web of Science ®Google Scholar
• Venkatesh B, Indira S, Srinivas P. Formulation and evaluation of glimepiride oral capsules. Int J Pharm Sci Invent. 2014;10:1–13.
   Google Scholar
• Yasser M, Gad S, El-sayed M, et al. The effect of converting liquid valsartan SNEDDS into solid SNEDDS using different solid carriers on its performance. Int J Bio Pharm Res. 2013;4:1015–1026.
   Google Scholar
• Shehata TM, Abdallah MH, Ibrahim MM. Proniosomal oral tablets for controlled delivery and enhanced pharmacokinetic properties of acemetacin. AAPS PharmSciTech. 2015;16:375–383.
   PubMed Web of Science ®Google Scholar
• Sonar GS, Jain D, More D. Preparation and in vitro evaluation of bilayer and floating-bioadhesive tablets of rosiglitazone maleate. Asian J Pharm Sci. 2007;2:161–169.
   Google Scholar
• Nagar P, Singh K, Chauhan I, et al. Orally disintegrating tablets: formulation, preparation techniques and evaluation. J App Pharm Sci. 2011;1:35–45.
   Google Scholar
• Paliwal R, Rai S, Vaidya B, et al. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine. 2009;5:184–191.
   PubMed Web of Science ®Google Scholar
• Riippi M, Antikainen O, Niskanen T, et al. The effect of compression force on surface structure, crushing strength, friability and disintegration time of erythromycin acistrate tablets. Eur J Pharm Biopharm. 1998;46:339–345.
   PubMed Web of Science ®Google Scholar
• Pawar PS, Saleem M. Formulation and evaluation of oral colon targeted tablet of budesonide. Pharm Lett. 2013;5:1–12.
   Google Scholar
• Gaur PK, Mishra S, Bajpai M. Formulation and evaluation of controlled-release of telmisartan microspheres: In vitro/in vivo study. J Food Drug Anal. 2014;22:542–548.
   PubMed Web of Science ®Google Scholar
• Chávez-Piña AE, Favari L, Castañeda-Hernández G. Pharmacokinetics of acemetacin and its active metabolite indomethacin in rats during acute hepatic damage and liver regeneration. Ann Hepatol. 2009;8:141–147.
   PubMed Web of Science ®Google Scholar
• Cheng C, Chen M-L, Tseng C, et al. A relative bioavailability study of 500 mg calcium p-aminosalicylate film coating tablet in healthy individuals. J Food Drug Anal. 2014;22:242–247.
   Web of Science ®Google Scholar
• Bhat LR, Godge RK, Vora AT, et al. Validated Rp‐HPLC method for simultaneous determination of Telmisartan and Hydrochlorothiazide in pharmaceutical formulation. J Liquid Chromatogr Relat Technol. 2007;30:3059–3067.
   Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Ser B. 1995; 57:289–300.
   Google Scholar
• Vora B, Khopade AJ, Jain N. Proniosome based transdermal delivery of levonorgestrel for effective contraception. J Control Release. 1998;54:149–165.
   PubMed Web of Science ®Google Scholar
• Kesisoglou F, Panmai S, Wu Y. Nanosizing—oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev. 2007;59:631–644.
   PubMed Web of Science ®Google Scholar
• Younes NF, Abdel-Halim SA, Elassasy AI. Solutol HS15 based binary mixed micelles with penetration enhancers for augmented corneal delivery of sertaconazole nitrate: optimization, in vitro, ex vivo and in vivo characterization. Drug Deliv. 2018;25:1706–1717.
   PubMed Web of Science ®Google Scholar
• Khattab WM, Gad S, El-sayed MM, et al. Bucco-adhesive delivery system for an anti-migraine drug: in-vitro/ex-vivo evaluation. J Pharm Pharm Sci. 2013;2:4225–4248.
   Google Scholar
• Jadon RS, Nayak S, Amlan S, et al. Taste masking of Lornoxicam by polymer carrier system and formulation of oral disintegrating tablets. Int J Drug Deliv. 2009;1:27–31.
   Google Scholar
• Salamat-Miller N, Chittchang M, Johnston TP. The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev. 2005;57:1666–1691.
   PubMed Web of Science ®Google Scholar
• Basu B, Bagadiya A, Makwana S, et al. Design and evaluation of sublimed orodispersible tablets of Cetrizine HCl using superdisintegrant blends by direct compression. Int J Pharm Pharm Sci. 2011;3:435–441.
   Google Scholar
• Saydam M, Takka S. Bioavailability file: valsartan T. FABAD J Pharm Sci. 2007;32:185–196.
   Google Scholar
• Vinod KR, Sravya K, Sandhya S, et al. Tailoring active compounds across biological membranes by cubosomal technology: an updated review. J Chinese Pharm Sci. 2013;22:303–313.
   Google Scholar
• Kurade V, Pai M, Gude R. RP-HPLC estimation of ramipril and telmisartan in tablets. Indian J Pharm Sci. 2009;71:148.
   PubMed Web of Science ®Google Scholar
• Cardot J, Beyssac E, Alric M. In vitro-in vivo correlation: importance of dissolution in IVIVC. Dissolution Technol. 2007;14:15.
   Web of Science ®Google Scholar